{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:10:02Z","timestamp":1784041802307,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","award":["PIP 2021\\u20132023 N \\u00B0 11220200102694CO"],"award-info":[{"award-number":["PIP 2021\\u20132023 N \\u00B0 11220200102694CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2019-0620"],"award-info":[{"award-number":["PICT 2019-0620"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009559","name":"National University of Quilmes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejpb.2025.114906","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:37Z","timestamp":1761519277000},"page":"114906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-2468","authenticated-orcid":false,"given":"Noelia","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Velurtas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Rivas Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-9207","authenticated-orcid":false,"given":"Mar\u00eda Jose","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-1746","authenticated-orcid":false,"given":"Eder L.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114906_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejpb.2025.114906_b0010","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ppul.24129","article-title":"Inflammation in cystic fibrosis: An update","volume":"53","author":"Roesch","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejpb.2025.114906_b0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/thorax.56.4.306","article-title":"Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis","volume":"56","author":"Henig","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.ejpb.2025.114906_b0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000446825","article-title":"Cystic fibrosis lung immunity: The role of the macrophage","volume":"8","author":"Bruscia","year":"2016","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.ejpb.2025.114906_b0025","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 study group, elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2025.114906_b0030","doi-asserted-by":"crossref","first-page":"0154","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ejpb.2025.114906_b0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejpb.2025.114906_b0040","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114906_b0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1513\/AnnalsATS.201706-486OC","article-title":"Association of high-dose ibuprofen use, lung function decline, and long-term survival in children with cystic fibrosis","volume":"15","author":"Konstan","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.ejpb.2025.114906_b0050","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1002\/ppul.24364","article-title":"Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators","volume":"54","author":"Perrem","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejpb.2025.114906_b0055","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3390\/molecules30112450","article-title":"Anti-inflammatory activity of thymol and thymol-rich essential oils: mechanisms, applications, and recent findings","volume":"30","author":"Gago","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2025.114906_b0060","series-title":"Essential Oils and Nanotechnology for Treatment of Microbial Diseases","first-page":"296","article-title":"Essential oil-based nanomedicines against trypanosomatides","author":"Morilla","year":"2017"},{"key":"10.1016\/j.ejpb.2025.114906_b0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/ph17081059","article-title":"Nanoparticle-based drug delivery systems in inhaled therapy: Improving respiratory medicine","volume":"17","author":"Cojocaru","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2025.114906_b0070","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/acs.molpharmaceut.1c00491","article-title":"Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases","volume":"18","author":"Pramanik","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114906_b0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114906_b0080","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2217\/nnm-2016-0437","article-title":"Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa","volume":"12","author":"Higa","year":"2017","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ejpb.2025.114906_b0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/acs.molpharmaceut.9b00721","article-title":"Fast biofilm penetration and anti-PAO1 activity of nebulized azithromycin in nanoarchaeosomes","volume":"17","author":"Altube","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114906_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154179","article-title":"Thymus vulgaris essential oil + tobramycin within nanostructured archaeolipid carriers: a new approach against Pseudomonas aeruginosa biofilms","volume":"102","author":"Perez","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejpb.2025.114906_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100531","article-title":"Tobramycin liquid crystal nanoparticles eradicate cystic fibrosis-related Pseudomonas aeruginosa biofilms","volume":"17","author":"Thorn","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2025.114906_b0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1166\/jbn.2018.2459","article-title":"The interplay between nanoparticles and neutrophils","volume":"14","author":"Lin","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2025.114906_b0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.nano.2012.02.008","article-title":"Ultradeformable archaeosomes as new topical adjuvants","volume":"8","author":"Higa","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114906_b0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0003-2670(61)80041-X","article-title":"A rapid and sensitive sub-micro phosphorus determination","volume":"24","author":"B\u00f6ttcher","year":"1961","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejpb.2025.114906_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110961","article-title":"Bacterioruberin from Haloarchaea plus dexamethasone in ultra-small macrophage-targeted nanoparticles as potential intestinal repairing agent","volume":"191","author":"Higa","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2025.114906_b0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2006.07.039","article-title":"A simple and sensitive fluorometric method for determination of gentamicin in liposomal suspensions","volume":"327","author":"Gubernator","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114906_b0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1099\/jmm.0.45969-0","article-title":"Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung","volume":"54","author":"Sriramulu","year":"2005","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114906_b0130","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1002\/eji.201243089","article-title":"NADPH oxidase derived reactive oxygen species are involved in human neutrophil IL-1\u03b2 secretion but not in inflammasome activation","volume":"43","author":"Gabelloni","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejpb.2025.114906_b0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.phymed.2018.12.025","article-title":"The anti-MRSA biofilm activity of Thymus vulgaris essential oil in nanovesicles","volume":"57","author":"Perez","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejpb.2025.114906_b0140","doi-asserted-by":"crossref","first-page":"91331","DOI":"10.3390\/pharmaceutics13091331","article-title":"Reparation of an inflamed air-liquid interface cultured A549 cells with nebulized nanocurcumin","volume":"13","author":"Altube","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114906_b0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1165\/rcmb.2021-0359OC","article-title":"Cystic fibrosis airway mucus hyperconcentration produces a vicious cycle of mucin, pathogen, and inflammatory interactions that promotes disease persistence","volume":"67","author":"Batson","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejpb.2025.114906_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2019.00406","article-title":"Nanomedicine approaches for the pulmonary treatment of cystic fibrosis","volume":"7","author":"Velino","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114906_b0155","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1021\/acsami.1c14975","article-title":"Hybrid lipid\/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs: does PEGylation make the difference?","volume":"14","author":"Conte","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2025.114906_b0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejpb.2017.12.017","article-title":"Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: proof of concept, challenges and pitfalls","volume":"124","author":"Nafee","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114906_b0165","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3762\/bjnano.15.46","article-title":"Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent","volume":"15","author":"Jerez","year":"2024","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ejpb.2025.114906_b0170","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2217\/nnm-2016-0165","article-title":"Surface-decorated nanoarchaeosomes for active targeting to inflamed lungs","volume":"11","author":"Altube","year":"2016","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.ejpb.2025.114906_b0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114906_b0180","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrmicro2199","article-title":"The type III secretion system of Pseudomonas aeruginosa: infection by injection","volume":"7","author":"Hauser","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114906_b0185","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/microorganisms13071527","article-title":"Biofilm formation of Pseudomonas aeruginosa in cystic fibrosis: mechanisms of persistence, adaptation, and pathogenesis","volume":"13","author":"Borisova","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejpb.2025.114906_b0190","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/infdis\/jit059","article-title":"The level of p38\u03b1 mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa","volume":"207","author":"Beaudoin","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejpb.2025.114906_b0195","first-page":"1","article-title":"P. aeruginosa-infected 3D co-culture of bronchial epithelial cells and macrophages at air-liquid interface for preclinical evaluation of anti-infectives","volume":"160","author":"Montefusco-Pereira","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejpb.2025.114906_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01438","article-title":"Role of cystic fibrosis bronchial epithelium in neutrophil chemotaxis","volume":"11","author":"Cabrini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2025.114906_b0205","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2025.114906_b0210","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/acs.jafc.6b00986","article-title":"Biological and nonbiological antioxidant activity of some essential oils","volume":"64","author":"P\u00e9rez-Ros\u00e9s","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2025.114906_b0215","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.bbrc.2019.02.142","article-title":"Stimulation of the class-a scavenger receptor induces neutrophil extracellular traps (NETs) by ERK dependent NOX2 and ROMO1 activation","volume":"511","author":"Zhu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2025.114906_b0220","article-title":"Ether lipids from archaeas in nano-drug delivery and vaccination","author":"Eder Romero","year":"2023","journal-title":"Int. J. Pharmaceutics 634"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:42:01Z","timestamp":1777592521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0939641125002838"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114906","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114906"}}